An Song

Title: An Song: Innovator in Biopharmaceutical Assays

Introduction

An Song is a notable inventor based in Palo Alto, CA, who has made significant contributions to the field of biopharmaceutical assays. With a total of 2 patents, his work focuses on improving the evaluation processes for therapeutic molecules.

Latest Patents

An Song's latest patents include innovative methods that enhance the understanding of molecule transcytosis and the pretreatment of biological samples. The first patent, titled "In vitro transcytosis assay," relates to methods and compositions useful for measuring the transcytosis of a molecule. This patent specifically addresses in vitro receptor-dependent transcytosis assays for evaluating the clearance rates of therapeutic antibody molecules and Fc-fusion proteins in humans and animals. The second patent, "Pretreatment of a biological sample from an autoimmune disease subject," describes a method for pretreating biological samples to avoid interference, particularly when the samples are subjected to cell-based biological activity assays, such as neutralizing antibody assays.

Career Highlights

An Song is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to contribute to advancements in therapeutic solutions for various diseases.

Collaborations

An Song has collaborated with talented coworkers, including Krista Maureen McCutcheon and Shan Chung, who share his commitment to innovation in the biopharmaceutical field.

Conclusion

An Song's contributions to biopharmaceutical assays through his patents demonstrate his dedication to advancing medical science. His work continues to impact the evaluation of therapeutic molecules, paving the way for future innovations in the industry.